Structural changes in the liver of mice with BCG granulomatosis and the use of oxidized dextran in age dynamics

In t r o d u c t i o n . Tubercular granulomatosis in newborns and children is much less common than in adults, and especially its visceral forms, including hepatic lesion. Oxidized dextran enhances the production of oxygen radicals, cytotoxic and bactericidal potential of phagocytes, accelerates the process of phagolysosomal fusion and elimination of the pathogen, reducing the granulomatous infl ammatory process in organs.
A i m . To study morphological changes in the liver of mice from the neonatal period to adulthood with the BCG vaccine administration and use of oxidized dextran.
Ma t e r i a l s  a n d  m e t h o d s . Mice of the C57B1/6 line (200 animals in total) were divided into 4 groups: mice from the 1st (intact) group were injected with 0.02 ml/kg of 0.9% sodium chloride solution on the fi rst day after birth. Mice from the 2nd group on the 2nd day after birth were injected with a solution of oxidized dextran with a molecular mass of 40 kDa. Mice from the 3rd group were injected with a solution of the BCG vaccine of 0.02 ml/kg on the fi rst day after birth. Mice of the 4th group were injected with a solution of the BCG vaccine of 0.02 ml/kg, on the second day after birth – a solution of oxidized dextran with a molecular mass of 40 kDa.
R e s u l t s . The numerical density (Nai) of granulomas in the liver progressively increased from 28th to 56th day of the experiment in mice of the 3rd and 4th groups by 13.5 times. However, in mice of the 4th group, the number of granulomas was 1.4 times less than in mice of the 3rd group. The diameter of granulomas in the liver in mice of the 4th group was smaller on the 28th and 56th days in comparison with the same indicator in mice of the 3rd group by 2 times and 1.3 times, respectively. In mice of the 4th group, the volume density (Vv) of degenerated hepatocytes from 3rd to 5th day was 8 times lower compared to the same indicator in mice of the 3rd group, on the 10th and 28th days – 1.7 and 1.2 times, respectively. Vv of foci of hepatocyte necrosis in mice of the 4th group did not diff er from that in mice of the 1st (intact) and 2nd (control) groups in all periods of observation, and was less on the 3rd and 56th days in comparison with the same indicator in mice of the 3rd (BCG) group by 3 times. On the 28th and 56th days of the experiment, mice from the 3rd and 4th groups showed an increase in the Nai of binuclear hepatocytes and hepatocytes with mitoses in comparison with the same indicator in mice of the 1st and 2nd groups. In mice of the 4th group, the number of binuclear hepatocytes, refl ecting the reparative regeneration of hepatocytes, was 1.8 times greater than in mice of the 3rd group on the 28th and 56th days.
Co n c l u s i o n . Granulomas formation (the number and diameter of granulomas) in the liver of mice with the admin-istration of the BCG vaccine and use of oxidized dextran was less marked in comparison with animals not treated with oxidized dextran, which indicates the eff ective elimination of the pathogen in phagocytes. Destructive changes (degeneration and necrosis of hepatocytes) in the liver parenchyma of mice with the injection of the BCG vaccine and subsequent use of oxidized dextran are signifi cantly reduced, while the processes of reparative regeneration in the liver parenchyma of mice are activated, which is due to the hepatotropic action of oxidized dextran.

1. Global Tuberculosis Report 2021 (2021). Geneva: World Health Organization. 57 p.

2. On the State of Sanitary and Epidemiological Wellbeing of the Population in the Russian Federation in 2019: State Report (2020). Moscow: Federal Service for the Oversight of Consumer Protection and Welfare. 299 p. (In Russ.)

3. Shkurupiy V.A. (2007). Tuberculous Granulomatosis. Cytophysiology and Targeted Therapy. Moscow: Publishing House of RAMS. 536 p. (In Russ.)

4. Tkachev V.O., Zaikovskaya M.V., Troitsky A.V., Luzgina N.G., Skurupy V.A. Oxidised dextrans infl uence on reactive oxygen species generation by murine peritoneal exudate phagocytic cells. Biomedical Chemistry. 2013;59(1):81–89. (In Russ.)

5. Starostenko A.A., Troitskii A.V., Medvedev V.S. et al. Studying pharmacokinetics of oxidized dextrans. Pharmaceutical Chemistry Journal. 2015;49(12):3–6. DOI: 10.30906/0023-1134-2015-49-12-3-6. (In Russ.)

6. Nadeev A.P., Skurupiy V.A., Marinkin I.O. (2014). The Liver and Placenta in the Peri- and Postnatal Periods in Pathology: Clinical and Experimental Study. Novosibirsk: Science. 244 p. (In Russ.)

7. Helmo F.R., Alves E.A.R., Moreira R.A.A. et al. Intrauterine infection, immune system and premature birth. J. Matern.-Fetal Neonatal Med. 2018;31(9):1227–1233. DOI: 10.1080/14767058.2017.1311318.

8. Upadhyay S., Mittal E., Philips J.A. Tuberculosis and the art of macrophage manipulation. Pathog. Dis. 2018;76(4):fty037. DOI: 10.1093/femspd/fty037.

9. Khan N., Vidyarthi A., Pahari S., Agrewala J.N. Distinct strategies employed by dendritic cells and macrophages in restricting Mycobacterium tuberculosis infection: Diff erent philosophies but same desire. Int. Rev. Immunol. 2016;35(5):386–398. DOI: 10.3109/08830185.2015.1015718.

10. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Rev. Immunol. 2008;8(12):958–969. DOI: 10.1038/nri2448.

11. Il’in D.A., Skurupiy V.A. The features of М1/М2 polarization of macrophages of BCG-infected mice in vitro. Bulletin of Experimental Biology and Medicine. 2020;169(4):449–451. (In Russ.)

12. Neshchadim D.V., Arkhipov S.A., Skurupiy V.A., Akhramenko E.S., Troitskiy A.V. Study of the eff ect of liposomal form of dextrazid on the expression of cathepsin B and D macrophages in vitro. The Siberian Scientifi c Medical Journal. 2017;37(6):16–21. (In Russ.)

13. Nakagaki B.N., Mafra K., de Carvalho E. et al. Immune and metabolic shifts during neonatal development reprogram liver identity and function. J. Hepatol. 2018;69(6):1294–1307. DOI: 10.1016/j.jhep.2018.08.018.

14. Alexander B., Guzail M.A., Foster C.S. Morphological changes during hepatocellular maturity in neonatal rats. Anat. Rec. 1997;248(1):104–109. DOI: 10.1002/(SICI)1097-0185(199705)248:1<104::AIDAR12>3.0.CO;2-T.

15. Mohareer K., Asalla S., Banerjee S. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection. Tuberculosis (Edinb.). 2018;113:99–121. DOI: 10.1016/j.tube.2018.09.007.

16. Skurupiy V.A., Karpov M.A., Klochin V.D. Eff ect of oxidized dextran on rat hepatocytes in toxic hepatosis of mixed etiology. The Siberian Scientifi c Medical Journal. 2021;41(5):25–30. DOI: 10.18699/SSMJ20210503. (In Russ.)

17. Fausto N., Campbell J.S., Riehle K.J. Liver regeneration. J. Hepatol. 2000;32(1):19–31.

18. Fujiyoshi M., Ozaki M. Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J. Hepatobiliary Pancreat. Sci. 2011;18(1):13–22. DOI: 10.1007/s00534-010-0304-2.

19. Wang C.P., Zhou L., Su S.H. et al. Augmenter of liver regeneration promotes hepatocyte proliferation induced by Kupffer cells. World J. Gastroenterol. 2006;12(30):4859–4865. DOI: 10.3748/wjg.v12.i30.4859.

20. Anatskaya O.V., Vinogradov A.E. Whole-genome duplication in evolution, ontogenesis and pathology: complexity and emergency reserve. Molecular Biology. 2021;55(6)927–943. DOI: 10.31857/S0026898421060021. (In Russ.)